CORD-19:e847d433e7424152a9846673209cb73027415ecd / 127526-127828
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/e847d433e7424152a9846673209cb73027415ecd","sourcedb":"CORD-19","sourceid":"e847d433e7424152a9846673209cb73027415ecd","text":"CTX-M producers showed diminished susceptibility to different antibiotics, such as CTX (94%), ceftriaxone (94%), CAZ (75%), aztreonam (94%), trimethoprim/sulfamethoxazole (88%), gentamicin (94%), amikacin (25%), ciprofloxacin (19%) among others; 81% of strains CTX-M producers were multidrug-resistant.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1237","span":{"begin":0,"end":302},"obj":"Sentence"},{"id":"T98675","span":{"begin":0,"end":302},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T1237","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T98675","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T282","span":{"begin":0,"end":302},"obj":"Sentence"}],"attributes":[{"subj":"T282","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#9793ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#a8ec93"}]}]}}